Watson's generic Toprol XL gains FDA approval

08/3/2009 | Reuters

The FDA approved Watson Pharmaceuticals' generic version of AstraZeneca's hypertension drug Toprol XL at 25 and 50 milligrams. The company hopes to also gain approval later this year for the drug at 100 and 200 milligrams.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX